ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Rybelsus N 9 mg, Tabletten - 30
69865004 Novo Nordisk Pharma AG
Rybelsus N 9 mg, Tabletten28.11.2025
  28.11.2025
Semaglutide (A10BJ06) 
WHO-DDD27.11.2030
07.06.20.30
07.06.20. 
B  
Yes 
IPCI
89.26Yes
    
10 %113.50
7680698650041Biotechnologika
  
Composition
semaglutidum 9 mg, natrii salcaprozas corresp. natrium 8 mg, magnesii stearas, pro compresso.
Packungsbestandteile
Tablets 
 
Active AgentDose
Semaglutidum9 mg
BAG: Active AgentDose
Semaglutidum9 mg
 
Inactive agents
Magnesii Stearas
Natrii Salcaprozas
Pro Compresso
 
Source
Data was imported : 09.01.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home